Documents
Briefs, oral arguments, agency decisions and the Federal Register.
254 results
0.32s
Approval of Respiratory Protective Devices
Federal Register · Rule · Sep 27, 2021
AND HUMAN SERVICES Public Health Service 42 CFR Part 84 Approval of Respiratory Protective Devices CFR Correction In Title 42 of the Code of Federal Regulations, Public Health, Parts 1 to 399 … [FR Doc. 2021-21061 Filed 9-24-21; 8:45 am] BILLING CODE 0099-10-P
86 FR 53228Health and Human Services DepartmentPublic Health ServiceAstraZeneca Pharmaceuticals LP; Withdrawal of Approval of a New Drug Application for IRESSA
Federal Register · Notice · Apr 25, 2012
, Drug, and Cosmetic Act (FD&C Act) (21 U.S.C. 355(e)) and § 314.150(d), and under authority delegated by the Commissioner to the Director, Center for Drug Evaluation and Research, approval of NDA 21-399 … [FR Doc. 2012-9944 Filed 4-24-12; 8:45 am] BILLING CODE 4160-01-P
77 FR 24723Health and Human Services DepartmentFood and Drug AdministrationFederal Register · Proposed Rule · Jun 3, 2009
Bed Size LTCHs were grouped into six categories based on bed size: 0-24 beds; 25-49 beds; 50-74 beds; 75-124 beds; 125-199 beds; and greater than 200 beds. … LTCHs in the bed size category of 0-24 beds are projected to experience a higher than average increase (2.8 percent) in estimated payments per discharge from the 2009 LTCH PPS rate year to the 2010 LTCH
74 FR 26600Health and Human Services DepartmentCenters for Medicare & Medicaid ServicesOncologic Drugs Advisory Committee; Notice of Meeting
Federal Register · Notice · Aug 27, 2002
Agenda : On September 24, 2002, the committee will discuss new drug application (NDA) 21-399, IRESSAr (gefitinib), AstraZeneca Pharmaceuticals LP, indicated for the treatment of patients with locally … Oral presentations from the public will be scheduled between approximately 8:45 a.m. and 9:45 a.m. on September 24, 2002. Time allotted for each presentation may be limited.
67 FR 55024Health and Human Services DepartmentFood and Drug AdministrationSpecifications for Medical Examinations of Coal Miners
Federal Register · Rule · Apr 27, 2015
DEPARTMENT OF HEALTH AND HUMAN SERVICES 42 CFR Part 37 Specifications for Medical Examinations of Coal Miners CFR Correction In Title 42 of the Code of Federal Regulations, Parts 1 to 399, revised … [FR Doc. 2015-09757 Filed 4-24-15; 8:45 am] BILLING CODE 1505-01-D
80 FR 23241Health and Human Services DepartmentFederal Register · Notice · Aug 4, 2011
Pending PMCs comprise 50 percent (201/399) of the on-schedule NDA/ANDA PMCs and 28 percent (66/236) of the on-schedule BLA PMCs. … ) Combined total 399 (84%) 236 (77%) 1 See note 1 for table 1 of this document.
76 FR 47211Health and Human Services DepartmentFood and Drug AdministrationFederal Register · Notice · Aug 23, 2016
DATES: Submit written comments on the collection of information by October 24, 2016. … SUPPLEMENTARY INFORMATION: The Alzheimer's Disease Supportive Services Program (ADSSP) is authorized through Sections 398, 399 and 399A of the Public Health Service (PHS) Act, as amended by Public Law
81 FR 57591Health and Human Services DepartmentCommunity Living AdministrationOffice of Rural Health Policy; Notice of Meetings
Federal Register · Notice · Apr 8, 2009
Dates and Times: April 24, 2009, 8 a.m.—3 p.m. in Albuquerque, NM. May 18, 2009, 8 a.m.—3 p.m. in Seattle, WA. June 26, 2009, 8 a.m.—3 p.m. in Omaha, NE. … The Omaha Marriott, 10220 Regency Circle, Omaha, NE 68114, Phone: 402-399-9000. Status: The meetings will be open to the public.
74 FR 15995Health and Human Services DepartmentHealth Resources and Services AdministrationMeeting of the Advisory Committee on Minority Health
Federal Register · Notice · Jan 13, 2020
Preregistration by January 24, 2020, is required for the public to attend the meeting, provide comments, and/or distribute printed material(s) to ACMH members. … Any individual who wishes to attend the meeting in person or by webcast must register by sending an email to OMH-ACMH@hhs.gov by January 24, 2020.
85 FR 1813Health and Human Services DepartmentFindings of Research Misconduct
Federal Register · Notice · Nov 25, 2014
Physiol. 545(2):399-406, 2002 • J. … [FR Doc. 2014-27813 Filed 11-24-14; 8:45 am] BILLING CODE P
79 FR 70187Health and Human Services DepartmentOffice of the SecretaryAgency Information Collection Activities: Submission for OMB Review; Comment Request
Federal Register · Notice · Mar 5, 2024
Form Number: CMS-10383 (OMB Control Number 0938-1389; Frequency: Occasionally; Affected Public: State Governments; Number of Respondents: 19; Total Annual Responses: 399; Total Annual … [FR Doc. 2024-04591 Filed 3-4-24; 8:45 am] BILLING CODE 4120-01-P
89 FR 15874Health and Human Services DepartmentCenters for Medicare & Medicaid ServicesNew Animal Drugs; Change of Sponsor; Fentanyl; Iron Injection
Federal Register · Rule · Jul 24, 2013
DATES: This rule is effective July 24, 2013. FOR FURTHER INFORMATION CONTACT: Steven D. … Mowbray, Leicestershire, England LE13 0PB has informed FDA that it has transferred ownership of, and all rights and interest in, NADA 099-667 for IMPOSIL (iron dextran complex) Injection and NADA 110-399
78 FR 44432Health and Human Services DepartmentFood and Drug AdministrationAgency Information Collection Activities; Proposed Collection; Comment Request
Federal Register · Notice · Apr 12, 2012
The length of time that individual families will participate in the study is up to 24 months. … The core of service system data will be collected every 18-24 months throughout the 5-year evaluation period.
77 FR 21986Health and Human Services DepartmentSubstance Abuse and Mental Health Services AdministrationFederal Register · Rule · May 25, 2021
Bd., 972 F.3d 586, 616 (4th Cir. 2020), as amended (Aug. 28, 2020), 5 reh'g en banc denied, 976 F.3d 399 (4th Cir. 2020), petition for cert. filed, No. 20-1163 (Feb. 24, 2021); Adams … [FR Doc. 2021-10477 Filed 5-24-21; 8:45 am] BILLING CODE 4153-01-P
86 FR 27984Health and Human Services DepartmentDetermination of Regulatory Review Period for Purposes of Patent Extension; XOFLUZA
Federal Register · Notice · Aug 8, 2024
The date the application was approved: October 24, 2018. FDA has verified the applicant's claim that NDA 210854 was approved on October 24, 2018. … In its application for patent extension, this applicant seeks 399 days of patent term extension. III.
89 FR 64920Health and Human Services DepartmentFood and Drug AdministrationFederal Register · Notice · Apr 30, 2020
Food and Drug Administration, et al., 399 F.Supp.3d 479 (D. Md. 2019). … Dated: April 24, 2020. Lowell J. Schiller, Principal Associate Commissioner for Policy. [FR Doc. 2020-09163 Filed 4-29-20; 8:45 am] BILLING CODE 4164-01-P
85 FR 23968Health and Human Services DepartmentFood and Drug AdministrationAgency Information Collection Activities: Submission for OMB Review; Comment Request
Federal Register · Notice · Jun 12, 2012
The length of time that individual families will participate in the study is up to 24 months. … The core of service system data will be collected every 18-24 months throughout the 5-year evaluation period.
77 FR 34961Health and Human Services DepartmentSubstance Abuse and Mental Health Services AdministrationAgency Information Collection Activities: Proposed Collection; Comment Request
Federal Register · Notice · Oct 17, 2023
On October 24, 2018, the Departments published guidance (86 FR 53575) that provided supplementary information about the requirements that must be met for the approval of a section 1332 waiver, the Secretaries … Form Number: CMS-10383 (OMB Control Number 0938-1389; Frequency: Occasionally; Affected Public: State Governments; Number of Respondents: 19; Total Annual Responses: 399; Total Annual
88 FR 71573Health and Human Services DepartmentCenters for Medicare & Medicaid ServicesFederal Register · Notice · Feb 8, 1999
150.62 2.09 88,417,899 NEW MEXICO............................... 117 0.9169 107.28 1.49 62,972,705 NEW YORK................................. 399 … 88,000,326 [[Page 6108]] NEW MEXICO............................... 117 0.9169 107.28 1.49 62,675,303 NEW YORK................................. 399
64 FR 6102Health and Human Services DepartmentHealth Care Finance AdministrationFederal Register · Rule · Feb 24, 2017
DATES: This rule is effective February 24, 2017, except for the amendment to 21 CFR 524.1465, which is effective March 6, 2017. FOR FURTHER INFORMATION CONTACT: George K. … Product name 21 CFR section 099-667 IMPOSIL (iron heptomer) Injection 522.1182 110-399 GLEPTOSIL (gleptoferron) Injection 522.1055 Following these changes of sponsorship, Sogeval
82 FR 11506Health and Human Services DepartmentFood and Drug Administration
Ask Donna what matters in the record.
She can read the source against your case and show you exactly where the answer came from.